Deep Track Capital, LP
Q1 2024 13F-HR Holdings
Net value change ($000)
+496,745
(16.6%)
New positions
19
Sold out positions
11
Turnover %
29.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AMGN | 156,376 | NEW |
| ALNY | 124,389 | NEW |
| DYN | 102,727 | 386.2% |
| APGE | 89,477 | 137.8% |
| OCUL | 74,596 | 181.2% |
| DFTX | 62,667 | NEW |
| APLS | 58,780 | NEW |
| KYMR | 50,742 | NEW |
| FDMT | 50,397 | 108.9% |
| IVVD | 48,635 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Ambrx Biopharma, Inc. | -52,836 | -100.0% |
| SRPT | -48,215 | -100.0% |
| RAPT | -44,580 | -100.0% |
| PACB | -42,420 | -61.8% |
| ACLX | -40,246 | -100.0% |
| Intra-Cellular Therapies, Inc. | -39,440 | -27.5% |
| INSM | -36,016 | -21.7% |
| Orchard Therapeutics plc | -33,585 | -100.0% |
| ANAB | -31,709 | -72.7% |
| EWTX | -27,757 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
12,138
(0.3% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|